MD Anderson Cancer Center Madrid Unidad de ensayos Clinicos

Madrid 28033

0 studies enrolling now · 1 studies all time

What they study most

Recurrent Platinum Resistant Ovarian Cancer

Studies at this site

• A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) — Completed